top of page

Polymer Factory Sweden AB signs material transfer agreement with big pharma

Polymer Factory Sweden AB (publ) has signed a material transfer agreement (MTA) with a major multinational pharmaceutical company. The MTA covers transfer of materials from its precision nanocarrier platform.

Polymer Factory has signed a material transfer agreement with the company for R&D purposes including use of customized products from Polymer Factory’s dendritic platform that are compatible with click chemistry, which was awarded the Nobel Prize in Chemistry 2022.

CTO Michael Malkoch:

“The signed agreement is a logical and important first step that defines the relationship between both parties and with respect to current and future delivered products covered by the MTA. Personally, I am quite excited over this relationship and as a company we will ensure to deliver high-quality customized precision nanocarriers for the internal evaluation by our customer. Polymer Factory will monitor the progress and support our customer with all means necessary to increase the success rate of our delivered products.”

This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 9 October 2022.

Find the full press release here:

Press release Oct 9
Download PDF • 181KB


bottom of page